Stille AB (STIL.ST)
SEK 184.5
(-1.07%)
SEK 184.5
(-1.07%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 62.94 Million SEK | -11.06% |
| 2022 | 70.76 Million SEK | -13.15% |
| 2021 | 81.48 Million SEK | 238.14% |
| 2020 | 24.09 Million SEK | -1.62% |
| 2019 | 24.49 Million SEK | 2973.4% |
| 2018 | 797 Thousand SEK | -50.25% |
| 2017 | 1.6 Million SEK | -28.0% |
| 2016 | 2.22 Million SEK | -22.12% |
| 2015 | 2.85 Million SEK | -24.64% |
| 2014 | 3.79 Million SEK | 320.29% |
| 2013 | 902 Thousand SEK | -87.23% |
| 2012 | 7.06 Million SEK | 80.41% |
| 2011 | 3.91 Million SEK | 84.46% |
| 2010 | 2.12 Million SEK | -71.51% |
| 2009 | 7.45 Million SEK | 23.74% |
| 2008 | 6.02 Million SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | - SEK | 0.0% |
| 2024 Q2 | - SEK | -100.0% |
| 2024 Q1 | 175.16 Million SEK | 178.3% |
| 2023 Q3 | 115.02 Million SEK | -0.78% |
| 2023 Q1 | 106.08 Million SEK | 49.91% |
| 2023 Q4 | 62.94 Million SEK | -45.28% |
| 2023 Q2 | 115.92 Million SEK | 9.28% |
| 2023 FY | 62.94 Million SEK | -11.06% |
| 2022 Q2 | 113.08 Million SEK | -1.36% |
| 2022 Q3 | 111.91 Million SEK | -1.04% |
| 2022 Q4 | 70.76 Million SEK | -36.77% |
| 2022 Q1 | 114.64 Million SEK | 40.7% |
| 2022 FY | 70.76 Million SEK | -13.15% |
| 2021 FY | 81.48 Million SEK | 238.14% |
| 2021 Q1 | 30.43 Million SEK | 26.31% |
| 2021 Q2 | 29.56 Million SEK | -2.87% |
| 2021 Q3 | 104.09 Million SEK | 252.11% |
| 2021 Q4 | 81.48 Million SEK | -21.73% |
| 2020 FY | 24.09 Million SEK | -1.62% |
| 2020 Q4 | 24.09 Million SEK | -1.96% |
| 2020 Q3 | 24.57 Million SEK | -5.33% |
| 2020 Q2 | 25.96 Million SEK | 0.58% |
| 2020 Q1 | 25.81 Million SEK | 5.38% |
| 2019 Q1 | - SEK | -100.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2019 Q4 | 24.49 Million SEK | 0.0% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 FY | 24.49 Million SEK | 2973.4% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 FY | 797 Thousand SEK | -50.25% |
| 2018 Q4 | 797 Thousand SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q1 | - SEK | -100.0% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 Q1 | - SEK | -100.0% |
| 2017 FY | 1.6 Million SEK | -28.0% |
| 2017 Q4 | 1.6 Million SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 Q1 | - SEK | -100.0% |
| 2016 FY | 2.22 Million SEK | -22.12% |
| 2016 Q4 | 2.22 Million SEK | 0.0% |
| 2016 Q3 | - SEK | 0.0% |
| 2015 Q2 | 2.03 Million SEK | -11.8% |
| 2015 Q1 | 2.3 Million SEK | -39.17% |
| 2015 FY | 2.85 Million SEK | -24.64% |
| 2015 Q4 | 2.85 Million SEK | 42.92% |
| 2015 Q3 | 1.99 Million SEK | -1.72% |
| 2014 Q3 | 4.15 Million SEK | 323.55% |
| 2014 Q2 | 981 Thousand SEK | -36.34% |
| 2014 Q1 | 1.54 Million SEK | 70.84% |
| 2014 FY | 3.79 Million SEK | 320.29% |
| 2014 Q4 | 3.79 Million SEK | -8.76% |
| 2013 Q2 | 7.66 Million SEK | 14.21% |
| 2013 Q1 | 6.71 Million SEK | -5.0% |
| 2013 FY | 902 Thousand SEK | -87.23% |
| 2013 Q3 | 985 Thousand SEK | -87.15% |
| 2013 Q4 | 902 Thousand SEK | -8.43% |
| 2012 Q2 | 10.08 Million SEK | 1.75% |
| 2012 Q1 | 9.91 Million SEK | 153.06% |
| 2012 Q3 | 10.43 Million SEK | 3.44% |
| 2012 Q4 | 7.06 Million SEK | -32.26% |
| 2012 FY | 7.06 Million SEK | 80.41% |
| 2011 Q2 | 2.52 Million SEK | 24.74% |
| 2011 Q1 | 2.02 Million SEK | -4.8% |
| 2011 FY | 3.91 Million SEK | 84.46% |
| 2011 Q3 | 4.54 Million SEK | 80.4% |
| 2011 Q4 | 3.91 Million SEK | -13.9% |
| 2010 Q1 | 3.22 Million SEK | -56.8% |
| 2010 FY | 2.12 Million SEK | -71.51% |
| 2010 Q4 | 2.12 Million SEK | -40.53% |
| 2010 Q3 | 3.57 Million SEK | 0.11% |
| 2010 Q2 | 3.56 Million SEK | 10.75% |
| 2009 FY | 7.45 Million SEK | 23.74% |
| 2009 Q4 | 7.45 Million SEK | 0.0% |
| 2009 Q2 | 5.82 Million SEK | -39.04% |
| 2009 Q1 | 9.55 Million SEK | 0.0% |
| 2008 FY | 6.02 Million SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 96.099% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 96.099% |
| Arcoma AB | 3.87 Million SEK | -1525.148% |
| Bactiguard Holding AB (publ) | 233.09 Million SEK | 72.998% |
| BICO Group AB (publ) | 1.85 Billion SEK | 96.603% |
| Boule Diagnostics AB (publ) | 166.1 Million SEK | 62.106% |
| CellaVision AB (publ) | 64.7 Million SEK | 2.722% |
| Clinical Laserthermia Systems AB (publ) | 454 Thousand SEK | -13763.877% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.8 Million SEK | -3396.778% |
| Duearity AB (publ) | 10.58 Million SEK | -494.802% |
| Dignitana AB (publ) | 19.1 Million SEK | -229.47% |
| Episurf Medical AB (publ) | 5.2 Million SEK | -1110.423% |
| Getinge AB (publ) | 8.07 Billion SEK | 99.221% |
| Scandinavian Real Heart AB (Publ) | 8.24 Million SEK | -662.968% |
| Iconovo AB (publ) | 7.72 Million SEK | -714.793% |
| Integrum AB (publ) | 6.42 Million SEK | -879.767% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -30450.81% |
| Mentice AB (publ) | 9.55 Million SEK | -558.596% |
| OssDsign AB (publ) | 3.15 Million SEK | -1898.159% |
| Paxman AB (publ) | 13.57 Million SEK | -363.832% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 20.73 Million SEK | -203.613% |
| SciBase Holding AB (publ) | 6.79 Million SEK | -826.026% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 31.78 Million SEK | -98.006% |
| Sedana Medical AB (publ) | 4.3 Million SEK | -1361.728% |
| Senzime AB (publ) | 11.46 Million SEK | -448.849% |
| SpectraCure AB (publ) | 6.71 Million SEK | -837.055% |
| Vitrolife AB (publ) | 2.08 Billion SEK | 96.987% |
| Xvivo Perfusion AB (publ) | 31.43 Million SEK | -100.216% |